NuVasive has completed the acquisition of a provider of Intra-Operative Monitoring (IOM) - Impulse Monitoring.
The acquisition allows NuVasive to increase both XLIF and non-lateral market share gains with hospitals and surgeons.
Under the acquisition, NuVasive will provide additional neuromonitoring services in the operating room.
The acquisition will increase the penetration of NuVasive’s proprietary nerve monitoring system – NeuroVision.
NeuroVision is designed for discreet and directional nerve avoidance and detection making lateral access to the spine during the XLIF procedure.